JA WP5 – Relative Effectiveness Assessment of Pharmaceuticals

Home  /  JA1 Archive (2010 – 2012)  /  JA WP5 – Relative Effectiveness Assessment of Pharmaceuticals


  • To develop principles, methodological guidance as well as functional online tools and policies for REA by identifying areas where methodological guidance is needed and by providing it, suggesting ways to integrate REA of pharmaceuticals as a special version of the Core Model
  • To test and implement a REA group of pharmaceuticals in line with the core HTA development.


  • A methodological guidance that will be appropiate for the assessment of relative effectiveness of pharmaceuticals
  • A relative effectiveness assessment of a (group) of pharmaceutical(s)

See the full list of WP5 products


Lead Partner


National Health Care Institute
(Zorginstituut Nederland)
Eekholt 4
NL-112XH Diemen
Telephone: +31 207979057
Fax: +31 (020) 797 8500

Co-Lead Partner

Associated Partners

Collaborating partners